Skip to content
10-Q

Quarterly Report

Sienna Biopharmaceuticals, Inc.

0001193125-19-141444

← back to feed
Filed
May 8, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · May 6, 2019 30.54M sh
Capex Q1 2019 · Mar 31, 2019 $4K
Capex Q1 2019 · Mar 31, 2018 $4K
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$12.77M
Operating Cash Flow Q1 2019 · Mar 31, 2018 −$14.46M
Long Term Debt Q1 2019 · Mar 31, 2019 $29.24M
Long Term Debt Q1 2019 · Dec 31, 2018 $30.13M
Cash And Equivalents Q1 2019 · Mar 31, 2019 $57.17M
Cash And Equivalents Q1 2019 · Dec 31, 2018 $48.53M
Stockholders Equity Q1 2019 · Mar 31, 2019 $33.29M
Stockholders Equity Q1 2019 · Dec 31, 2018 $26.58M
Stockholders Equity Q1 2019 · Mar 31, 2018 $76.42M
Stockholders Equity Q1 2019 · Dec 31, 2017 $91.2M
Current Liabilities Q1 2019 · Mar 31, 2019 $22.45M
Current Liabilities Q1 2019 · Dec 31, 2018 $24.35M
Total Liabilities Q1 2019 · Mar 31, 2019 $81.77M
Total Liabilities Q1 2019 · Dec 31, 2018 $80.73M
Current Assets Q1 2019 · Mar 31, 2019 $58.67M
Current Assets Q1 2019 · Dec 31, 2018 $50.41M
Total Assets Q1 2019 · Mar 31, 2019 $115.05M
Total Assets Q1 2019 · Dec 31, 2018 $107.31M
Sga Expense Q1 2019 · Mar 31, 2019 $8.75M
Sga Expense Q1 2019 · Mar 31, 2018 $5.5M
Rd Expense Q1 2019 · Mar 31, 2019 $7.09M
Rd Expense Q1 2019 · Mar 31, 2018 $12.98M
Net Income Q1 2019 · Mar 31, 2019 −$16.38M
Net Income Q1 2019 · Mar 31, 2018 −$17.1M
Operating Income Q1 2019 · Mar 31, 2019 −$15.84M
Operating Income Q1 2019 · Mar 31, 2018 −$18.48M